| LZ ALPHA | FRI · AUG 7, 2026 · 06:00 EST · ISSUE #218 |
The overnight tape is dominated by a flood of late congressional disclosures, especially Sen. Tuberville dumping long-delayed batches that reach back hundreds of days. The 8-K stack has real balance-sheet and dilution signals, led by VICI's $1.75B note deal and several stock-issuance/ATM structures. No qualifying insider Form 4 transaction data was supplied in today's feed, so the insider section is flagged accordingly rather than backfilled with invented signals.
| Type | Ticker | Signal | Flagged | Then | Now | Return |
|---|---|---|---|---|---|---|
| 8-K | ABBV | AbbVie Inc. | 2026-08-06 | $243.80 | $243.87 | ▲ 0.0% |
| 8-K | ATKR | Atkore Inc. | 2026-08-04 | $93.55 | $93.66 | ▲ 0.1% |
| 8-K | PLNH | Planet 13 Holdings Inc. | 2026-08-03 | $0.12 | $0.12 | ▲ 3.4% |
| 8-K | XAIR | Beyond Air, Inc. | 2026-08-01 | $5.42 | $5.56 | ▲ 2.6% |
The filing shows the largest 6 of 84 disclosed trades, with repeated joint-account sales of CLF and INTC in $100,001-$250,000 bands. The transactions date to May 2024 and were filed 814-817 days late.
The signal is less about a single ticker and more about scale, lateness, and concentration: a senator disclosed a multimillion-dollar, high-volume trading batch long after the statutory window. CLF and INTC are both politically exposed industrial/semiconductor names, making the delayed visibility material.
| CLF | Sell | STOCK | $100,001 - $250,000 |
| CLF | Sell | STOCK | $100,001 - $250,000 |
| INTC | Sell | STOCK | $100,001 - $250,000 |
| INTC | Sell | STOCK | $100,001 - $250,000 |
| CLF | Sell | STOCK | $100,001 - $250,000 |
| INTC | Sell | STOCK | $100,001 - $250,000 |
The largest 6 of 75 disclosed trades are all $1,001-$15,000 line items, including a FITB exchange tied to Comerica stock following a merger, paired NOW buy/sell activity, PEG buy/sell activity and a CMS sale. Many of the trades were filed 184-240 days late.
The individual line items are small, but the total filing size and lateness make it notable. The FITB/Comerica exchange is the cleanest corporate-action signal, while the broader pattern looks like portfolio maintenance rather than concentrated directional risk.
| FITB | Buy | STOCK | $1,001 - $15,000 |
| NOW | Buy | STOCK | $1,001 - $15,000 |
| NOW | Sell | STOCK | $1,001 - $15,000 |
| PEG | Sell | STOCK | $1,001 - $15,000 |
| PEG | Buy | STOCK | $1,001 - $15,000 |
| CMS | Sell | STOCK | $1,001 - $15,000 |
The filing shows the largest 6 of 15 trades: a $50,001-$100,000 purchase of USIG and $15,001-$50,000 sales of MSFT, MA, LLY, GS and DUK. The trades occurred on April 15, 2025 and were filed 477 days late.
The pattern looks like de-risking from individual large-cap equities into investment-grade credit exposure. The late reporting again reduces contemporaneous transparency, and the names span tech, payments, pharma, financials and utilities.
| USIG | Buy | STOCK | $50,001 - $100,000 |
| MSFT | Sell | STOCK | $15,001 - $50,000 |
| MA | Sell | STOCK | $15,001 - $50,000 |
| LLY | Sell | STOCK | $15,001 - $50,000 |
| GS | Sell | STOCK | $15,001 - $50,000 |
| DUK | Sell | STOCK | $15,001 - $50,000 |
The filing includes 5 spouse-owned partial sales on July 21, led by a $15,001-$50,000 MSFT sale and smaller sales of CSCO, KO, INTC and AAPL. It was filed 14 days after the trades and was not late.
This is smaller than the Tuberville and Delaney filings, but it is current and concentrated in widely held mega-cap tech and defensive consumer exposure. Watch whether this was isolated trimming or the start of broader spouse-account de-risking.
| MSFT | Sell | STOCK | $15,001 - $50,000 |
| CSCO | Sell | STOCK | $1,001 - $15,000 |
| KO | Sell | STOCK | $1,001 - $15,000 |
| INTC | Sell | STOCK | $1,001 - $15,000 |
| AAPL | Sell | STOCK | $1,001 - $15,000 |
The largest 6 of 62 disclosed trades show multiple $15,001-$50,000 purchases, including LTH, FWONK, CHRW and SGI, alongside a TSCO partial sale. These were recent transactions from July 27-31 and were filed within days.
Unlike the Tuberville dump, this is current portfolio activity and reads like active rotation into cyclical and consumer-experience exposure. The breadth matters: 62 trades in one filing suggests a managed sleeve rather than a one-off conviction bet, but the July timing makes it actionable.
| LTH | Buy | STOCK | $15,001 - $50,000 |
| FWONK | Buy | STOCK | $15,001 - $50,000 |
| CHRW | Buy | STOCK | $15,001 - $50,000 |
| SGI | Buy | STOCK | $15,001 - $50,000 |
| FWONK | Buy | STOCK | $15,001 - $50,000 |
| TSCO | Sell | STOCK | $15,001 - $50,000 |
The feed provided to analyze does not include insider Form 4 records with a true _transaction.has_transaction field. No open-market purchase, sale, option exercise, or award data was available to validate.
Per the rules, insider signals should not be fabricated from missing or unparsed data. The absence itself means this category should be treated as unavailable for today's run.
No source record with reporting owner, issuer ticker, transaction code, shares, price and value was supplied. The category lacks the minimum transaction detail required for inclusion.
Open-market purchases are the highest-conviction insider signal, but none were present in the provided data. Leaving this as N/A avoids assigning false significance.
The input did not include any validated Form 4 transaction object for an insider at a public company. All insider fields are therefore unavailable.
Without a specific source record, using a ticker, dollar value, or reporting owner would be fabrication. This slot is intentionally marked unavailable.
No insider transaction with parsed shares, price per share, total value and transaction code was supplied. The data supports no primary insider entry.
Routine grants and exercises would already rank below open-market buys, but even those details were not provided. The right read is no qualifying data, not a weak inferred signal.
The supplied dataset contains congressional and 8-K records, but no usable insider Form 4 transaction records. There is no doc_url to copy for a specific insider filing.
This preserves data integrity: every insider signal must tie to a concrete reporting owner and exact filing URL. No such record was available.
| Company / Issuer | Filed | Source |
|---|---|---|
| SEI INVESTMENTS CO | 2026-08-06 | EDGAR ↗ |
| Eos Energy Enterprises, Inc. | 2026-08-06 | EDGAR ↗ |
| CLEARONE INC | 2026-08-06 | EDGAR ↗ |
| M/I HOMES, INC. | 2026-08-06 | EDGAR ↗ |
| Mastercard Inc | 2026-08-06 | EDGAR ↗ |
| Mastercard Inc | 2026-08-06 | EDGAR ↗ |
| GRAN TIERRA ENERGY INC. | 2026-08-06 | EDGAR ↗ |
| GRAN TIERRA ENERGY INC. | 2026-08-06 | EDGAR ↗ |
| GRAN TIERRA ENERGY INC. | 2026-08-06 | EDGAR ↗ |
| GRAN TIERRA ENERGY INC. | 2026-08-06 | EDGAR ↗ |
VICI Properties L.P. agreed to issue $900M of 5.400% senior notes due 2031 and $850M of 5.750% senior notes due 2036. Net proceeds are estimated at about $1.720B, with the offering expected to close on August 14, 2026.
The risk is not buried in litigation language; it is in the capital structure. For a rate-sensitive REIT, the coupon, maturity ladder and use of proceeds will matter for AFFO spread, refinancing flexibility and investor appetite for long-duration real estate credit.
Ensysce acquired Cy Biopharma on August 5, 2026 and issued Cy equityholders the right to receive 282,122 shares of Series C Preferred Stock. Each preferred share is convertible into 1,000 shares of common stock, subject to conditions.
The headline is a merger, but the buried market risk is the conversion math: 282,122 preferred shares times 1,000 implies up to 282.122M common shares before considering conditions. For a small biotech issuer, that is a high-dilution structure investors need to model immediately.
Aclaris entered into a Second Amended and Restated Sales Agreement with Leerink Partners and Cantor Fitzgerald to sell common stock from time to time under an at-the-market program. The prior agreement provided for up to $100.0M of common stock sales, and the agents will receive a 3.0% commission on gross proceeds.
The company is not obligated to sell, but an active ATM is an overhang for biotech holders because issuance can quietly pressure rallies. The key watch is whether financing activity accelerates around clinical, regulatory, or cash-runway milestones.
Sunrise Realty Trust entered into a merger agreement with Southern Realty Trust, Sunrise Merger Sub and, for limited purposes, Sunrise Manager LLC. The deal includes an issuance of SUNS common stock, was reviewed by a special committee of independent and disinterested directors, and will be submitted for stockholder consideration.
The risk sits in governance and dilution: a stock-funded REIT merger involving an external manager can reshape ownership and economics. The special committee language helps, but investors should watch exchange terms, related-party economics and the stockholder vote.
The supplied filing text is largely cover-page and XBRL-style metadata for Equity Residential and ERP Operating Limited Partnership, with Item 8.01 and 9.01 listed. The excerpt references a member label for 7.57% notes due August 15, 2026, but the actual Item 8.01 narrative terms are not visible in the supplied text.
Because the operative text is unavailable in the excerpt, this should be treated as a watch item rather than a high-confidence risk call. For a large apartment REIT, any note-related disclosure can matter, but the market signal depends on the missing terms.
| Company / Issuer | Filed | Source |
|---|---|---|
| ERP OPERATING LTD PARTNERSHIP | 2026-08-06 | EDGAR ↗ |
| VICI Properties L.P. | 2026-08-06 | EDGAR ↗ |
| ZW Data Action Technologies Inc. (CNET) | 2026-08-06 | EDGAR ↗ |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2026-08-06 | EDGAR ↗ |
| Organogenesis Holdings Inc. (ORGO) | 2026-08-06 | EDGAR ↗ |
| Grace Therapeutics, Inc. (GRCE) | 2026-08-06 | EDGAR ↗ |
| INNODATA INC (INOD) | 2026-08-06 | EDGAR ↗ |
| Clearway Energy, Inc. (CWEN) | 2026-08-06 | EDGAR ↗ |
| PULSE BIOSCIENCES, INC. (PLSE) | 2026-08-06 | EDGAR ↗ |
| HYDROFARM HOLDINGS GROUP, INC. (HYFM) | 2026-08-06 | EDGAR ↗ |
| AAPL | $312.41 | -0.05% |
| MSFT | $499.86 | +0.18% |
| NVDA | $218.99 | -0.20% |
| AMZN | $272.26 | +0.03% |
| GOOGL | $357.75 | -0.32% |
| META | $589.90 | +0.14% |
| TSLA | $319.53 | -0.29% |
| NFLX | $73.69 | +0.07% |
| JPM | $356.30 | -0.19% |
| AMD | $489.28 | -0.49% |
| BRVE | +65.6% | $29.80 |
| IOVA | +43.1% | $6.21 |
| INSM | +33.9% | $132.55 |
| SITM | +26.6% | $687.50 |
| WPP | +25.9% | $25.95 |
| PAYC | +23.6% | $215.97 |
| VAC | +22.6% | $124.75 |
| CAI | +21.6% | $20.00 |
| CACI | +21.4% | $628.79 |
| CHYM | +20.6% | $31.25 |
| FTDR | +17.7% | $89.92 |
| DXPE | +17.7% | $198.21 |
| MGNI | +17.7% | $24.32 |
| FA | +17.3% | $24.12 |
| PRAX | +15.9% | $370.16 |
| DIOD | +15.3% | $98.72 |
| U | +15.1% | $40.81 |
| MTSI | +14.5% | $301.64 |
| DGII | +14.1% | $83.01 |
| ZLAB | +13.7% | $20.88 |
| BLLN | -38.9% | $91.65 |
| HONA | -23.2% | $156.47 |
| APP | -19.7% | $335.67 |
| HUBS | -19.1% | $202.43 |
| DDOG | -19.0% | $229.29 |
| BROS | -18.8% | $53.33 |
| FOUR | -18.8% | $43.36 |
| CELH | -18.5% | $23.77 |
| VISN | -18.2% | $10.10 |
| PTON | -15.6% | $5.50 |
| EPAM | -15.3% | $93.07 |
| DAVE | -15.1% | $365.26 |
| SYM | -14.9% | $39.60 |
| FIG | -14.8% | $23.97 |
| GRAL | -14.5% | $63.40 |
| AXON | -14.3% | $522.46 |
| BLBD | -14.2% | $66.01 |
| ESTA | -13.4% | $79.05 |
| CHRN | -13.3% | $20.25 |
| KVYO | -13.3% | $16.73 |